Previous CTX treatment of adrenocortical tumors in inhα/Tag mice (Vuorenoja et al. 2009) showed tumor regression, which was attributed to systemic effect through inhibition of LH release. This evidence concerns the gene PLOD1 and adrenal cortex neoplasm.